Discontinuation report ZERIT - CAP 40MG

Last updated on 2018-07-11 History
Report ID 55462
Drug Identification Number 02216116
Brand name ZERIT - CAP 40MG
Common or Proper name STAVUDINE
Company Name BRISTOL-MYERS SQUIBB CANADA
Active Ingredient(s) STAVUDINE
Strength(s) 40MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 1 BTL x 60
ATC code J05AF
ATC description DIRECT ACTING ANTIVIRALS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-03-31
Actual discontinuation date
Remaining supply date 2020-03-31
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply All strengths are being deleted.
Company comments
Health Canada comments
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
MONTRÉAL (ST-LAURENT), QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2018-07-11 French Compare
v1 2018-07-11 English Compare